[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.65.227. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Comment & Response
January 2015

Laboratory Testing for Lyme Neuroborreliosis

Author Affiliations
  • 1Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
JAMA Neurol. 2015;72(1):125-126. doi:10.1001/jamaneurol.2014.3552

To the Editor In their Viewpoint published in JAMA Neurology, Melia et al1 discussed diagnosis of Lyme disease, a tick-borne infection caused by the spirochete Borrelia burgdorferi, focusing primarily on the disease’s affliction of the central nervous system, which is a condition commonly referred to as neuroborreliosis.

When it comes to laboratory testing for neuroborreliosis, the authors particularly emphasized the usefulness and pitfalls of serologic testing including IgG and IgM immunoblots as well as assessment of the B burgdorferi antibody ratio between cerebrospinal fluid (CSF) and blood. We fully agree that serologic testing represents one of the key elements in the diagnostic workup of patients with suspected neuroborreliosis. However, we believe that in a clinical setting, additional basic CSF analyses should be taken into account along with the clinical assessment.

First Page Preview View Large
First page PDF preview
First page PDF preview
×